Skip to main content

Healthy Women

5
Pipeline Programs
4
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
4 programs
1
2
1
Mona Lisa® NT Cu380 MiniPhase 31 trial
Levonorgestrel butanoatePhase 21 trial
NES-E2 CVRPhase 21 trial
levonorgestrel butanoatePhase 11 trial
Active Trials
NCT04143659Active Not Recruiting136Est. Mar 2026
NCT07222228Not Yet Recruiting165Est. Mar 2029
NCT03432416Completed385Est. Dec 2021
+1 more trials
Lundbeck
LundbeckDenmark - Copenhagen
1 program
1
Encapsulated vortioxetine IR tablet, 20 mgPhase 11 trial
Active Trials
NCT02112903Completed40
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Transcranial Magnetic Stimulation ActiveN/A1 trial
Active Trials
NCT07363421RecruitingEst. Jun 2026
Evestra
EvestraTX - San Antonio
1 program
EVE119 vaginal ringPHASE_11 trial
Active Trials
NCT05994599Completed36Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Human BioSciencesMona Lisa® NT Cu380 Mini
Human BioSciencesLevonorgestrel butanoate
Human BioSciencesNES-E2 CVR
EvestraEVE119 vaginal ring
Human BioScienceslevonorgestrel butanoate
LundbeckEncapsulated vortioxetine IR tablet, 20 mg
City TherapeuticsTranscranial Magnetic Stimulation Active

Clinical Trials (7)

Total enrollment: 1,867 patients across 7 trials

NCT03124160Human BioSciencesMona Lisa® NT Cu380 Mini

Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

Start: May 2017Est. completion: Jun 20221,105 patients
Phase 3Completed
NCT07222228Human BioSciencesLevonorgestrel butanoate

A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception

Start: Apr 2026Est. completion: Mar 2029165 patients
Phase 2Not Yet Recruiting

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Start: Feb 2018Est. completion: Dec 2021385 patients
Phase 2Completed
NCT05994599EvestraEVE119 vaginal ring

Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring

Start: Jul 2023Est. completion: Dec 202336 patients
Phase 1Completed
NCT04143659Human BioScienceslevonorgestrel butanoate

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Start: Mar 2020Est. completion: Mar 2026136 patients
Phase 1Active Not Recruiting
NCT02112903LundbeckEncapsulated vortioxetine IR tablet, 20 mg

Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women

Start: Apr 201440 patients
Phase 1Completed
NCT07363421City TherapeuticsTranscranial Magnetic Stimulation Active

TMS-Induced LH Response in Healthy Women in Luteal Phase

Start: Feb 2026Est. completion: Jun 2026
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 1,867 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.